| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 423 | 920 | 370 | $60 | $360.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 241 | 820 | 390 | $70 | $245K |
| 90460 | In this procedure, the provider administers a single live attenuated vaccine through a parenteral, oral, intranasal, intramuscular, or intravenous to a patient up to 18 years of age. | 125 | 250 | 660 | $40 | $172.7K |
| 99393 | The provider performs an established well–patient visit for a child who is between the ages of 5 and 11. | 111 | 170 | 500 | $100 | $170.6K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 150 | 360 | 370 | $50 | $153.6K |
| 99394 | The provider performs an established well–patient visit for an adolescent who is between the ages of 12 and 17. | 97 | 160 | 190 | $110 | $129.7K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 93 | 160 | 260 | $30 | $54.2K |
| 87880 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect Streptococcus, group A, in a patient sample, typically a throat swab. | 139 | 260 | 350 | $10 | $30.5K |
| 87804 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect influenza, also called flu, in a patient sample, typically a throat or nasal swab or nasal washings. | 117 | 250 | 330 | $10 | $29.9K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 18 | 30 | 220 | $10 | $20.8K |